Inovio Pharmaceuticals INO reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Inovio Pharmaceuticals missed estimated earnings by 5.88%, reporting an EPS of $-0.36 versus an estimate of $-0.34.
Revenue was down $172.05 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.18 which was followed by a 5.86% drop in the share price the next day.
Here's a look at Inovio Pharmaceuticals's past performance:
Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
---|---|---|---|---|
EPS Estimate | -0.32 | -0.33 | -0.25 | -0.18 |
EPS Actual | -0.50 | -0.29 | -0.39 | -0.27 |
Revenue Estimate | 2.84M | 970.00K | 1.21M | 850.00K |
Revenue Actual | 839.00K | 291.70K | 272.82K | 371.12K |
To track all earnings releases for Inovio Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.